Centers for Disease Control and Prevention, Emerging Infectious Diseases, 12(21), p. 2186-2189, 2015
Full text: Download
We investigated the kinetics of serologic responses to Middle East respiratory syndrome coronavirus (MERS-CoV) infection by using virus neutralization and MERS-CoV S1 IgG ELISA tests. In most patients, robust antibody responses developed by the third week of illness. Delayed antibody responses with the neutralization test were associated with more severe disease.